|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income/(loss) | |||||
| Adjustments to reconcile net income/(loss) to net cash provided by: | |||||
| Depreciation (property and equipment, internal-use software and website development) | |||||
| Amortization of intangible assets | |||||
| Goodwill impairment loss | |||||
| Goodwill and intangible assets impairment loss | |||||
| Impairment of long-lived assets including internal-use software and website development | |||||
| Share-based compensation | |||||
| Deferred income taxes | |||||
| Foreign exchange (gains)/losses | |||||
| Expected credit losses, net | |||||
| Gain on deconsolidation of subsidiaries | |||||
| Gain on disposal of fixed assets | |||||
| Gain from settlement of asset retirement obligation | |||||
| Gain from lease termination and modification, net | |||||
| Loss from equity method investments | |||||
| Gain on step acquisition | |||||
| Gain on sale of intangible assets | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, including related party | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Payroll liabilities | |||||
| Accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Advances from travelers | |||||
| Taxes payable/receivable, net | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchase of investments | |||||
| Proceeds from sales and maturities of investments | |||||
| Business acquisition, net of cash acquired | |||||
| Capital expenditures, including internal-use software and website development | |||||
| Investment in equity-method investees | |||||
| Proceeds from sale of fixed assets | |||||
| Proceeds from sale of intangible assets | |||||
| Proceeds from receipt of tax credits | |||||
| Net cash provided by/(used in) investing activities | |||||
| Financing activities: | |||||
| Proceeds from exercise of option awards | |||||
| Payment of withholding taxes on net share settlements of equity awards | |||||
| Repayment of other non-current liabilities | |||||
| Purchases of treasury stock | |||||
| Dividend paid to shareholders | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase/(decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Cash received for interest | |||||
| Cash paid for taxes, net of (refunds) | |||||
| Non-cash investing and financing activities: | |||||
| Fixed assets-related payable | |||||
| Receipt of tax credits | |||||
Loading...